NEW YORK (GenomeWeb News) – Corning has signed an agreement with HighRes Biosolutions to develop consumables for customers conducting medium- to high-throughput screening, the company said yesterday.
The next-generation consumables will be manufactured and sold exclusively through the Corning Life Sciences unit of the diversified materials science firm but co-marketed by both firms. They expect to launch the new products in the first quarter of 2009.
HighRes Biosolutions is a Woburn, Mass.-based developer of automated systems instruments used in high-throughput screening.
“This agreement enables Corning and HighRes to leverage their relative strengths in the HTS market and deliver unique, next-generation medium- to high-throughput solutions,” Robb D’Amore, business director of Corning Life Sciences, said in a statement.